Consistent with published data18,20,21, samples of co-occurring endometriosis in some of our adenomyosis patients bore both KRAS and PIK3CA mutations (Fig. 1d and Supplementary Data 12), whereas most co-occurring leiomyoma samples harbored MED12 mutations (Fig. 1e). The gene discussed is KRAS; the disease is adenomyosis.